beta-Cyclopentyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-propanenitrile-d8 is an intermediate in the synthesis of Ruxolitinib (R701995), a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis. Molecular Formula: C17H18D8BN3O2 Solubility: DCM, Methanol Molecular Weight: 323.27 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molecular Weight:
323.27
Form:
Supplied as a White Solid
* VAT and and shipping costs not included. Errors and price changes excepted